Hematology Analyzers and Reagents Market: Global Market Opportunity Assessment Study 2025 by Sysmex (Japan), Danaher (US), Nihon Kohden (Japan), Siemens (Germany), Abbott Laboratories (US), Boule Diagnostics (Sweden), HORIBA (Japan)

This report, using SWOT analysis and Porter's Five Forces tool, will help the reader understand market drivers and restrictions. The review of the 2017 base year's historic year and 2016 shows that some progress will be made on the Hematology Analyzers and Reagents Market in 2018-2025. Hematology Analyzers and Reagents Market Report is an in-depth study of the Medical Devices industry explaining what market definitions, classifications, applications, commitments and global trends are.

Hematology Analyzers and Reagents Market is divided into products, applications, end users and regions. Eventually, calculated movements will be made by the best players and brands on the market including certain product launches, research, joint ventures, mergers and acquisitions. Indeed, the market report from Hematology Analyzers and Reagents Market gives all the top performers and brands profiles of the company. The new strategic plan and suggestions that will help old as well as new market players to maintain the competitiveness are also discussed.

Get Sample PDF of Report at https://databridgemarketresearch.com/request-a-sample/?dbmr=global-hematology-analyzers-and-reagents-market

Global Hematology Analyzers and Reagents Market, By Products & Services (Hematology Analyzers (5 Parts, 6 Parts, 3 Part, Poc, Semi-Automated), Hemostasis, Immunohematology), Test (Closed Vial Testing, Open Sampling Testing), Price Range (High, Low), Application(Anemias, Blood Cancers, Hemorrhagic Conditions, Infection Related Conditions, Immune system related conditions, Blood Clot VTE, Others), End User (Government Labs), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)– Industry Trends and Forecast to 2025

The Global Hematology Analyzers and Reagents Market is expected to reach USD 5.9 billion by 2025, from USD 3.0 billion in 2017 growing at a CAGR of 8.6% during the forecast period of 2018 to 2025.

Hematology analyzers are preferably used to run tests on blood samples to detect blood related disorders such as anaemia, leukemia, myelofibrosis, blood transfusion, malignant lymphomas, and bone marrow stem cell transplantation. These analyzers have various application in medical field such white blood cells counts, complete blood count, reticulocyte analysis and coagulation tests.

For instance, according to the Centre of Disease Control and Prevention (CDC), number of people affected by VTE (blood clots) in U.S. was 350,000 to 900,000 cases per year and number of deaths caused by blood clots are 100,000 to 300,000. Hence, growing the rate of blood disorders will lead the growth of hematology analyzers in forecast year.

In July 2017, Sysmex (U.S.) launched XN-L automated hematology analyzers. XN-L analyzers offers six-part differential which includes immature granulocyte analysis on each sample in compact footprint.

Reasons to Purchase this Report

• Current and future of global hematology analyzers and reagents market outlook in the developed and emerging markets

• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.

• Regions/countries that are expected to witness the fastest growth rates during the forecast period

• The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report

• The report includes the complete segmentation displayed above across all above mentioned countries

• All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Some of the major players operating in the global hematology analyzers and reagents market are:

• Sysmex (Japan),

• Danaher (US),

• Nihon Kohden (Japan),

• Siemens (Germany),

• Abbott Laboratories (US),

• Boule Diagnostics (Sweden),

• HORIBA (Japan),

• Bio-Rad Laboratories (US),

• BioSystems (Spain),

• Diatron (Hungary),

• Drew Scientific (US),

• EKF Diagnostics (UK),

• Mindray (China),

• Ortho Clinical Diagnostics (US),

• Beckman Coulter Diagnostics (India),

• Roche (Switzerland),

• Among others

Market Segmentation: Global Hematology Analyzers and Reagents Market

The global hematology analyzers and reagents market is segmented based on product and services, test, end user and geographical segments.

Based on product and services, the market is segmented hematology analyzers, hemostasis and immunohematology. the hematology analyzers segment is further sub-segmented 5 Parts, 6 Parts, 3 Part, PoC and Semi-Automated.

Based on test, the market is segmented into closed vial testing and open sampling testing.

Based on application, the market is segmented anemias, blood cancers, hemorrhagic conditions, infection related conditions and immune system related conditions, blood clot VTE and others.

Based on end user, the market is segmented into Government labs.

Based on geography, the market report covers data points for 28 countries across multiple geographies namely North America & South America, Europe, Asia-Pacific and, Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and Brazil among others.

Market Drivers and Restraints:

• Increasing incidences of blood disorders

• Rising awareness towards the blood donation

• Technological advancement in the hematology analyzers and reagents

• Integration with the flow cytometry techniques

Get Instant Discount | Contact us at https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-hematology-analyzers-and-reagents-market

Key Developments in the Market:

In march, 2018, Roche (Europe) announced U.S. FDA approval of hematology testing solution, the cobas m 511 integrated hematology analyser. The cobas m 511 analyzer, featured with patented Bloodhound technology which addresses challenges of hematology testing by combining a cell counter, slide maker and stainer and a digital morphology analyzer into one integrated solution.

Table of Contents:

1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Global, By Component
7. Product Type
8. Delivery
9. Industry Type
10. Geography
10.1. Overview
10.2. North America
10.3. Europe
10.4. Asia-Pacific
10.5. South America
10.6. Middle East & Africa
11. Company Landscape
12. Company Profiles
13. Related Reports

Access Detailed TOC at https://databridgemarketresearch.com/toc/?dbmr=global-hematology-analyzers-and-reagents-market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.